Most people think COVID-19 will raise drug prices and health insurance premiums
According to a new survey, 90 percent of Americans are “very” or “somewhat” worried that COVID-19 will cause high drug
Read More
Health Care Finance
The demand for long-term care insurance is still there
Although insurers may be scared of chronic care benefits, but a recent data from Massachusetts Mutual Life Insurance Company suggest
Read MoreGeneric remdesivir to cost up to $79 per dose
(By Alia Paavola for Becker’s Hospital Review) Two generic drugmakers, Cipla and Hetero, were given the green light from Indian regulators
Read MoreInsurers May Only Pay For Coronavirus Tests When They’re ‘Medically Necessary’
(By Blake Farmer for NPR) In the wake of the massive turnout at anti-racism demonstrations around the country, public health
Read MoreLimitations of the Program for Uninsured COVID-19 Patients Raise Concerns
(By Karyn Schwartz and Jennifer Tolbert for Kaiser Family Foundation) In early April, the Department of Health and Human Services
Read MoreNearly 90% of Americans worried about drug price hikes
(ByKatie Adams for Becker’s Hospital Review) Nearly 90 percent of Americans expressed concern about drugmakers using the pandemic as an
Read MorePeople with dementia experience significantly higher costs of care
A study funded by National Institute on Aging found people with dementia experience significantly higher costs of care compared to
Read MoreMedPAC recommends accelerating the transition to value-based payment reform
In a nonbinding report to Congress, the Medicare Payment Advisory Commission (MedPAC) recommends accelerating the transition to value-based payment reform
Read MoreMedicare’s Trust Fund is in trouble too
We always hear that Social Security is in trouble, which is true, but do you know Medicare is strained too?
Read MoreAt A Time Of Great Need, Public Health Lacks ‘Lobbying Muscle’
(By Angela Hart for Kaiser Health News) SACRAMENTO — If there were ever a time for more public health funding,
Read More